# Službeni list C 213/26.

| | ISSN 1977-1088 |
| --- | --- |
| Službeni list
  Europske unije | C 213 |
| | |
| Hrvatsko izdanje | Informacije i objave | Godište 63.26. lipnja 2020. |

ISSN 1977-1088

Službeni list

Europske unije

C 213

Hrvatsko izdanje

Informacije i objave

Godište 63.26. lipnja 2020.

---

| Sadržaj | Stranica |
| --- | --- |
| | IV.   Obavijesti |
| | OBAVIJESTI INSTITUCIJA, TIJELA, UREDA I AGENCIJA EUROPSKE UNIJE |
| | Europska komisija |
| 2020/C 213/01 | Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 1. listopada 2018. do 31. prosinca 2019.(Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća) | 1 |
| 2020/C 213/02 | Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 1. svibnja 2020. do 31. svibnja 2020.(Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća) | 3 |

Sadržaj

Stranica

IV.   Obavijesti

OBAVIJESTI INSTITUCIJA, TIJELA, UREDA I AGENCIJA EUROPSKE UNIJE

Europska komisija

2020/C 213/01

Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 1. listopada 2018. do 31. prosinca 2019.(Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća)

(Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća)

1

2020/C 213/02

Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 1. svibnja 2020. do 31. svibnja 2020.(Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća)

(Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća)

3

---

| HR | |
| --- | --- |

HR

---

IV. Obavijesti

OBAVIJESTI INSTITUCIJA, TIJELA, UREDA I AGENCIJA EUROPSKE UNIJE

Europska komisija

| 26.6.2020 | HR | Službeni list Europske unije | C 213/1 |
| --- | --- | --- | --- |

26.6.2020

HR

Službeni list Europske unije

C 213/1

---

Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 1. listopada 2018. do 31. prosinca 2019.

(Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća (1))

(2020/C 213/01)

—   Izmjena odobrenja za stavljanje u promet (članak 13. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

| Datum odluke | Naziv lijeka | Nositelj odobrenja za stavljanje u promet | Broj upisa u registar Zajednice | Datum obavijesti |
| --- | --- | --- | --- | --- |
| 29.10.2018. | Eporatio | ratiopharm GmbH
  Graf-Arco-Straße 3, 89079 Ulm, Deutschland | EU/1/09/573 | 31.10.2018. |
| 29.10.2018. | Viramune | Boehringer Ingelheim International GmbH
  Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland | EU/1/97/055 | 31.10.2018. |
| 28.11.2018. | Keppra | UCB Pharma S.A.
  Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef 60, 1070 Brussel, België | EU/1/00/146 | 30.11.2018. |
| 28.11.2018. | Pioglitazone Teva | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/12/757 | 30.11.2018. |
| 28.11.2018. | Pioglitazone Teva Pharma | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/12/758 | 30.11.2018. |
| 28.11.2018. | Spinraza | Biogen Netherlands B.V.
  Prins Mauritslaan 13, 1171 LP Badhoevedorp, Nederland | EU/1/17/1188 | 30.11.2018. |
| 20.12.2018. | Vimizim | BioMarin International Limited
  Shanbally, Ringaskiddy, County Cork, P43 R298, Ireland | EU/1/14/914 | 24.1.2019. |
| 11.4.2019. | Apidra | Sanofi-Aventis Deutschland GmbH
  D-65926 Frankfurt am Main, Deutschland | EU/1/04/285 | 16.4.2019. |
| 15.4.2019. | Orencia | Bristol-Myers Squibb Pharma EEIG
  Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland | EU/1/07/389 | 17.4.2019. |
| 6.6.2019. | Glustin | Takeda Pharma A/S
  Dybendal Alle 10, 2630 Taastrup, Danmark | EU/1/00/151 | 11.6.2019. |
| 27.6.2019. | Xeljanz | Pfizer Europe MA EEIG
  Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/Pleinlaan 17, 1050 Brussel, België | EU/1/17/1178 | 1.7.2019. |
| 23.8.2019. | NutropinAq | Ipsen Pharma
  65 quai Georges Gorse, 92100 Boulogne-Billancourt, France | EU/1/00/164 | 27.8.2019. |
| 23.9.2019. | Zebinix | Bial – Portela & Ca, SA
  À Av. da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Portugal | EU/1/09/514 | 25.9.2019. |
| 29.10.2019. | Inhixa | Techdow Pharma Netherlands B.V.
  Strawinskylaan 1143, Toren C-11, 1077 XX Amsterdam, Nederland | EU/1/16/1132 | 15.11.2019. |
| 22.11.2019. | Flixabi | Samsung Bioepis NL B.V.
  Olof Palmestraat 10, 2616 LR Delft, Nederland | EU/1/16/1106 | 26.11.2019. |

Datum odluke

Naziv lijeka

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Datum obavijesti

29.10.2018.

Eporatio

ratiopharm GmbH

Graf-Arco-Straße 3, 89079 Ulm, Deutschland

EU/1/09/573

31.10.2018.

29.10.2018.

Viramune

Boehringer Ingelheim International GmbH

Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland

EU/1/97/055

31.10.2018.

28.11.2018.

Keppra

UCB Pharma S.A.

Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef 60, 1070 Brussel, België

EU/1/00/146

30.11.2018.

28.11.2018.

Pioglitazone Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/12/757

30.11.2018.

28.11.2018.

Pioglitazone Teva Pharma

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/12/758

30.11.2018.

28.11.2018.

Spinraza

Biogen Netherlands B.V.

Prins Mauritslaan 13, 1171 LP Badhoevedorp, Nederland

EU/1/17/1188

30.11.2018.

20.12.2018.

Vimizim

BioMarin International Limited

Shanbally, Ringaskiddy, County Cork, P43 R298, Ireland

EU/1/14/914

24.1.2019.

11.4.2019.

Apidra

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main, Deutschland

EU/1/04/285

16.4.2019.

15.4.2019.

Orencia

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland

EU/1/07/389

17.4.2019.

6.6.2019.

Glustin

Takeda Pharma A/S

Dybendal Alle 10, 2630 Taastrup, Danmark

EU/1/00/151

11.6.2019.

27.6.2019.

Xeljanz

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/Pleinlaan 17, 1050 Brussel, België

EU/1/17/1178

1.7.2019.

23.8.2019.

NutropinAq

Ipsen Pharma

65 quai Georges Gorse, 92100 Boulogne-Billancourt, France

EU/1/00/164

27.8.2019.

23.9.2019.

Zebinix

Bial – Portela & Ca, SA

À Av. da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Portugal

EU/1/09/514

25.9.2019.

29.10.2019.

Inhixa

Techdow Pharma Netherlands B.V.

Strawinskylaan 1143, Toren C-11, 1077 XX Amsterdam, Nederland

EU/1/16/1132

15.11.2019.

22.11.2019.

Flixabi

Samsung Bioepis NL B.V.

Olof Palmestraat 10, 2616 LR Delft, Nederland

EU/1/16/1106

26.11.2019.

—   Izmjena odobrenja za stavljanje u promet (članak 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

| Datum odluke | Naziv lijeka | Nositelj odobrenja za stavljanje u promet | Broj upisa u registar Zajednice | Datum obavijesti |
| --- | --- | --- | --- | --- |
| 26.4.2019. | ERYSENG | Laboratorios Hipra, S.A.
  Avda. La Selva, 135, 17170 Amer (Girona), España | EU/2/14/166 | 30.4.2019. |
| 29.8.2019. | BROADLINE | Boehringer Ingelheim Vetmedica GmbH
  D-55216 Ingelheim am Rhein, Deutschland | EU/2/13/157 | 2.9.2019. |
| 29.8.2019. | VarroMed | BeeVital GmbH
  Wiesenbergstrasse 19,A- 5164, Seeham, Österreich | EU/2/16/203 | 2.9.2019. |

Datum odluke

Naziv lijeka

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Datum obavijesti

26.4.2019.

ERYSENG

Laboratorios Hipra, S.A.

Avda. La Selva, 135, 17170 Amer (Girona), España

EU/2/14/166

30.4.2019.

29.8.2019.

BROADLINE

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/13/157

2.9.2019.

29.8.2019.

VarroMed

BeeVital GmbH

Wiesenbergstrasse 19,A- 5164, Seeham, Österreich

EU/2/16/203

2.9.2019.

Zainteresirane osobe koje žele na uvid dobiti javno izvješće o procjeni predmetnih lijekova i odluka koje se na njih odnose trebale bi se obratiti:

| European Medicines Agency |
| --- |
| Domenico Scarlattilaan 6 |
| 1083 HS Amsterdam |
| NIZOZEMSKA |

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NIZOZEMSKA

---

(1)  SL L 136, 30.4.2004., str. 1.

---

| 26.6.2020 | HR | Službeni list Europske unije | C 213/3 |
| --- | --- | --- | --- |

26.6.2020

HR

Službeni list Europske unije

C 213/3

---

Sažetak odluka Europske unije o odobrenjima za stavljanje u promet lijekova od 1. svibnja 2020. do 31. svibnja 2020.

(Objavljeno u skladu s člankom 13. ili člankom 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća (1))

(2020/C 213/02)

—   Izdavanje odobrenja za stavljanje u promet (članak 13. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

| Datum odluke | Naziv lijeka | INN (medunarodni nezašticeni naziv lijeka) | Nositelj odobrenja za stavljanje u promet | Broj upisa u registar Zajednice | Farmaceutski oblik | Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova) | Datum obavijesti |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 18.5.2020. | Zolgensma | onasemnogen abeparvovek | AveXis EU Limited
  Block B, The Crescent Building, Northwood, Santry, Dublin 9, D09 C6X8, Ireland | EU/1/20/1443 | Otopina za infuziju | M09AX09 | 18.5.2020. |
| 20.5.2020. | Fluad Tetra | Cjepivo protiv influence (površinski antigen) inaktivirano, adjuvantirano | Seqirus Netherlands B.V.
  Paasheuvelweg 28, 1105 BJ Amsterdam, Netherlands | EU/1/20/1433 | Suspenzija za injekciju u napunjenoj štrcaljki (injekcija). | J07BB02 | 26.5.2020. |
| 20.5.2020. | Nepexto | etanercept | Mylan IRE Healthcare Limited
  Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13 Ireland | EU/1/20/1436 | Otopina za injekciju | L04AB01 | 29.5.2020. |
| 30.5.2020. | Atectura Breezhaler | indakaterol/mometazonfuroat | Novartis Europharm Limited
  Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland | EU/1/20/1439 | Prašak inhalata, tvrda kapsula | R03AK14 | 2.6.2020. |
| 30.5.2020. | Bemrist Breezhaler | indakaterol/mometazonfuroat | Novartis Europharm Limited
  Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland | EU/1/20/1441 | Prašak inhalata, tvrda kapsula | R03AK | 2.6.2020. |
| 30.5.2020. | Sarclisa | isatuksimab | Sanofi-Aventis groupe
  54 rue La Boétie, 75008 Pariz, France | EU/1/20/1435 | Koncentrat za otopinu za infuziju | L01XC38 | 3.6.2020. |

Datum odluke

Naziv lijeka

INN (medunarodni nezašticeni naziv lijeka)

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Farmaceutski oblik

Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova)

Datum obavijesti

18.5.2020.

Zolgensma

onasemnogen abeparvovek

AveXis EU Limited

Block B, The Crescent Building, Northwood, Santry, Dublin 9, D09 C6X8, Ireland

EU/1/20/1443

Otopina za infuziju

M09AX09

18.5.2020.

20.5.2020.

Fluad Tetra

Cjepivo protiv influence (površinski antigen) inaktivirano, adjuvantirano

Seqirus Netherlands B.V.

Paasheuvelweg 28, 1105 BJ Amsterdam, Netherlands

EU/1/20/1433

Suspenzija za injekciju u napunjenoj štrcaljki (injekcija).

J07BB02

26.5.2020.

20.5.2020.

Nepexto

etanercept

Mylan IRE Healthcare Limited

Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13 Ireland

EU/1/20/1436

Otopina za injekciju

L04AB01

29.5.2020.

30.5.2020.

Atectura Breezhaler

indakaterol/mometazonfuroat

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/20/1439

Prašak inhalata, tvrda kapsula

R03AK14

2.6.2020.

30.5.2020.

Bemrist Breezhaler

indakaterol/mometazonfuroat

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/20/1441

Prašak inhalata, tvrda kapsula

R03AK

2.6.2020.

30.5.2020.

Sarclisa

isatuksimab

Sanofi-Aventis groupe

54 rue La Boétie, 75008 Pariz, France

EU/1/20/1435

Koncentrat za otopinu za infuziju

L01XC38

3.6.2020.

—   Izmjena odobrenja za stavljanje u promet (članak 13. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

| Datum odluke | Naziv lijeka | Nositelj odobrenja za stavljanje u promet | Broj upisa u registar Zajednice | Datum obavijesti |
| --- | --- | --- | --- | --- |
| 4.5.2020. | Axura | Merz Pharmaceuticals GmbH
  Eckenheimer Landstraße 100 D-60318 Frankfurt am Main, Deutschland | EU/1/02/218 | 8.5.2020. |
| 4.5.2020. | Bortezomib Accord | Accord Healthcare S.L.U.
  World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España | EU/1/15/1019 | 12.5.2020. |
| 4.5.2020. | Bronchitol | Pharmaxis Europe Limited
  108 Q House, Furze Road, Sandyford Dublin 18, D18AY29, Ireland | EU/1/12/760 | 5.5.2020. |
| 4.5.2020. | Clopidogrel Apotex | Apotex Europe B.V.
  Archimedesweg 2, 2333 CN Leiden, Nederland | EU/1/09/568 | 6.5.2020. |
| 4.5.2020. | Clopidogrel Mylan | Mylan S.A.S.
  117 allée des Parcs, 69800 Saint Priest, France | EU/1/09/559 | 5.5.2020. |
| 4.5.2020. | Clopidogrel Teva | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/09/540 | 7.5.2020. |
| 4.5.2020. | Cystadrops | Recordati Rare Diseases
  Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France | EU/1/15/1049 | 6.5.2020. |
| 4.5.2020. | Ferriprox | Chiesi Farmaceutici S.p.A.
  Via Palermo 26/A, 43122 Parma, Italia | EU/1/99/108 | 7.5.2020. |
| 4.5.2020. | Grepid | Pharmathen S.A.
  6 Dervenakion, 15351 Pallini Attiki, Ελλάδα | EU/1/09/535 | 5.5.2020. |
| 4.5.2020. | Ilumetri | Almirall, S.A.
  Ronda General Mitre, 151, 08022 Barcelona, España | EU/1/18/1323 | 5.5.2020. |
| 4.5.2020. | Pemetrexed Krka | KRKA, d.d.
  Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija | EU/1/18/1283 | 12.5.2020. |
| 4.5.2020. | Pemetrexed medac | medac Gesellschaft für klinische Spezialpräparate mbH
  Theaterstraße 6, 22880 Wedel, Deutschland | EU/1/15/1038 | 12.5.2020. |
| 4.5.2020. | Raxone | Santhera Pharmaceuticals (Deutschland) GmbH
  Marie-Curie Straße 8, 79539 Lörrach, Deutschland | EU/1/15/1020 | 14.5.2020. |
| 4.5.2020. | Tafinlar | Novartis Europharm Limited
  Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland | EU/1/13/865 | 8.5.2020. |
| 4.5.2020. | Wilzin | Recordati Rare Diseases
  Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France | EU/1/04/286 | 5.5.2020. |
| 4.5.2020. | Xultophy | Novo Nordisk A/S
  Novo Allé, 2880 Bagsvaerd, Danmark | EU/1/14/947 | 6.5.2020. |
| 5.5.2020. | Naglazyme | BioMarin International Limited
  Shanbally, Ringaskiddy, County Cork P43 R298, Ireland | EU/1/05/324 | 6.5.2020. |
| 12.5.2020. | ADCETRIS | Takeda Pharma A/S
  Dybendal Alle 10, 2630 Taastrup, Danmark | EU/1/12/794 | 19.5.2020. |
| 12.5.2020. | Clopidogrel Krka | KRKA d d., Novo mesto
  Šmarješka cesta 6, 8501 Novo mesto, Slovenija | EU/1/09/556 | 13.5.2020. |
| 12.5.2020. | Movymia | STADA Arzneimittel AG
  Stadastraße 2-18, 61118 Bad Vilbel, Deutschland | EU/1/16/1161 | 13.5.2020. |
| 12.5.2020. | Pemetrexed Hospira | Pfizer Europe MA EEIG
  Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/Pleinlaan 17, 1050 Brussel, België | EU/1/15/1057 | 14.5.2020. |
| 12.5.2020. | Segluromet | Merck Sharp & Dohme B.V.
  Waarderweg 39, 2031 BN Haarlem, Nederland | EU/1/18/1265 | 14.5.2020. |
| 12.5.2020. | Steglatro | Merck Sharp & Dohme B.V.
  Waarderweg 39, 2031 BN Haarlem, Nederland | EU/1/18/1267 | 14.5.2020. |
| 12.5.2020. | Steglujan | Merck Sharp & Dohme B.V.
  Waarderweg 39, 2031 BN Haarlem, Nederland | EU/1/18/1266 | 14.5.2020. |
| 12.5.2020. | Vedrop | Recordati Rare Diseases
  Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France | EU/1/09/533 | 13.5.2020. |
| 14.5.2020. | Clopidogrel Krka d.d. | KRKA d d., Novo mesto
  Šmarješka cesta 6, 8501 Novo mesto, Slovenija | EU/1/09/562 | 18.5.2020. |
| 14.5.2020. | Firdapse | SERB S.A.
  Avenue Louise 480, 1050 Bruxelles, Belgique/Louizalaan 480, 1050 Brussel, België | EU/1/09/601 | 15.5.2020. |
| 14.5.2020. | Yellox | Bausch Health Ireland Limited
  3013 Lake Drive, Citywest Business Campus, Dublin 24, D24PPT3, Ireland | EU/1/11/692 | 15.5.2020. |
| 18.5.2020. | Signifor | Recordati Rare Diseases
  Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France | EU/1/12/753 | 19.5.2020. |
| 20.5.2020. | Daxas | AstraZeneca AB
  151 85 Södertälje, Sverige | EU/1/10/636 | 28.5.2020. |
| 20.5.2020. | Ivabradine Anpharm | ANPHARM Przedsiębiorstwo Farmaceutyczne S.A.
  ul. Annopol 6B, 03–236 Warszawa, Polska | EU/1/15/1041 | 25.5.2020. |
| 20.5.2020. | Jorveza | Dr. Falk Pharma GmbH
  Leinenweberstraße 5, 79041 Freiburg im Breisgau, Deutschland | EU/1/17/1254 | 26.5.2020. |
| 20.5.2020. | Lenvima | Eisai GmbH
  Lyoner Straße 36, 60528 Frankfurt am Main, Deutschland | EU/1/15/1002 | 26.5.2020. |
| 20.5.2020. | LIBTAYO | Regeneron Ireland Designated Activity Company (DAC)
  Europa House, Harcourt Centre, Harcourt Street, Dublin 2, Ireland | EU/1/19/1376 | 26.5.2020. |
| 20.5.2020. | Nplate | Amgen Europe B.V.
  Minervum 7061, 4817 ZK Breda, Nederland | EU/1/08/497 | 25.5.2020. |
| 20.5.2020. | Odomzo | Sun Pharmaceutical Industries Europe BV
  Polarisavenue 87, 2132 JH Hoofddorp, Nederland | EU/1/15/1030 | 28.5.2020. |
| 20.5.2020. | Onpattro | Alnylam Netherlands B.V.
  Strawinskylaan 3051, 1077 ZX, Amsterdam, Nederland | EU/1/18/1320 | 25.5.2020. |
| 20.5.2020. | Pregabalin Zentiva | Zentiva, k.s.
  U Kabelovny 130, 102 37 Praha 10, Česká republika | EU/1/15/1021 | 25.5.2020. |
| 20.5.2020. | Revestive | Shire Pharmaceuticals Ireland Limited
  Block 2 & 3 Miesian Plaza, 50-58 Baggot Street Lower, D02 Y754 Dublin 2, Ireland | EU/1/12/787 | 11.6.2020. |
| 20.5.2020. | Tybost | Gilead Sciences Ireland UC
  Carrigtohill, County Cork, T45 DP77, Ireland | EU/1/13/872 | 25.5.2020. |

Datum odluke

Naziv lijeka

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Datum obavijesti

4.5.2020.

Axura

Merz Pharmaceuticals GmbH

Eckenheimer Landstraße 100 D-60318 Frankfurt am Main, Deutschland

EU/1/02/218

8.5.2020.

4.5.2020.

Bortezomib Accord

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

EU/1/15/1019

12.5.2020.

4.5.2020.

Bronchitol

Pharmaxis Europe Limited

108 Q House, Furze Road, Sandyford Dublin 18, D18AY29, Ireland

EU/1/12/760

5.5.2020.

4.5.2020.

Clopidogrel Apotex

Apotex Europe B.V.

Archimedesweg 2, 2333 CN Leiden, Nederland

EU/1/09/568

6.5.2020.

4.5.2020.

Clopidogrel Mylan

Mylan S.A.S.

117 allée des Parcs, 69800 Saint Priest, France

EU/1/09/559

5.5.2020.

4.5.2020.

Clopidogrel Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/09/540

7.5.2020.

4.5.2020.

Cystadrops

Recordati Rare Diseases

Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France

EU/1/15/1049

6.5.2020.

4.5.2020.

Ferriprox

Chiesi Farmaceutici S.p.A.

Via Palermo 26/A, 43122 Parma, Italia

EU/1/99/108

7.5.2020.

4.5.2020.

Grepid

Pharmathen S.A.

6 Dervenakion, 15351 Pallini Attiki, Ελλάδα

EU/1/09/535

5.5.2020.

4.5.2020.

Ilumetri

Almirall, S.A.

Ronda General Mitre, 151, 08022 Barcelona, España

EU/1/18/1323

5.5.2020.

4.5.2020.

Pemetrexed Krka

KRKA, d.d.

Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/18/1283

12.5.2020.

4.5.2020.

Pemetrexed medac

medac Gesellschaft für klinische Spezialpräparate mbH

Theaterstraße 6, 22880 Wedel, Deutschland

EU/1/15/1038

12.5.2020.

4.5.2020.

Raxone

Santhera Pharmaceuticals (Deutschland) GmbH

Marie-Curie Straße 8, 79539 Lörrach, Deutschland

EU/1/15/1020

14.5.2020.

4.5.2020.

Tafinlar

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/13/865

8.5.2020.

4.5.2020.

Wilzin

Recordati Rare Diseases

Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France

EU/1/04/286

5.5.2020.

4.5.2020.

Xultophy

Novo Nordisk A/S

Novo Allé, 2880 Bagsvaerd, Danmark

EU/1/14/947

6.5.2020.

5.5.2020.

Naglazyme

BioMarin International Limited

Shanbally, Ringaskiddy, County Cork P43 R298, Ireland

EU/1/05/324

6.5.2020.

12.5.2020.

ADCETRIS

Takeda Pharma A/S

Dybendal Alle 10, 2630 Taastrup, Danmark

EU/1/12/794

19.5.2020.

12.5.2020.

Clopidogrel Krka

KRKA d d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/09/556

13.5.2020.

12.5.2020.

Movymia

STADA Arzneimittel AG

Stadastraße 2-18, 61118 Bad Vilbel, Deutschland

EU/1/16/1161

13.5.2020.

12.5.2020.

Pemetrexed Hospira

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/Pleinlaan 17, 1050 Brussel, België

EU/1/15/1057

14.5.2020.

12.5.2020.

Segluromet

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/18/1265

14.5.2020.

12.5.2020.

Steglatro

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/18/1267

14.5.2020.

12.5.2020.

Steglujan

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/18/1266

14.5.2020.

12.5.2020.

Vedrop

Recordati Rare Diseases

Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France

EU/1/09/533

13.5.2020.

14.5.2020.

Clopidogrel Krka d.d.

KRKA d d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/09/562

18.5.2020.

14.5.2020.

Firdapse

SERB S.A.

Avenue Louise 480, 1050 Bruxelles, Belgique/Louizalaan 480, 1050 Brussel, België

EU/1/09/601

15.5.2020.

14.5.2020.

Yellox

Bausch Health Ireland Limited

3013 Lake Drive, Citywest Business Campus, Dublin 24, D24PPT3, Ireland

EU/1/11/692

15.5.2020.

18.5.2020.

Signifor

Recordati Rare Diseases

Immeuble Le Wilson, 70 avenue du Général de Gaulle, 92 800 Puteaux, France

EU/1/12/753

19.5.2020.

20.5.2020.

Daxas

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/10/636

28.5.2020.

20.5.2020.

Ivabradine Anpharm

ANPHARM Przedsiębiorstwo Farmaceutyczne S.A.

ul. Annopol 6B, 03–236 Warszawa, Polska

EU/1/15/1041

25.5.2020.

20.5.2020.

Jorveza

Dr. Falk Pharma GmbH

Leinenweberstraße 5, 79041 Freiburg im Breisgau, Deutschland

EU/1/17/1254

26.5.2020.

20.5.2020.

Lenvima

Eisai GmbH

Lyoner Straße 36, 60528 Frankfurt am Main, Deutschland

EU/1/15/1002

26.5.2020.

20.5.2020.

LIBTAYO

Regeneron Ireland Designated Activity Company (DAC)

Europa House, Harcourt Centre, Harcourt Street, Dublin 2, Ireland

EU/1/19/1376

26.5.2020.

20.5.2020.

Nplate

Amgen Europe B.V.

Minervum 7061, 4817 ZK Breda, Nederland

EU/1/08/497

25.5.2020.

20.5.2020.

Odomzo

Sun Pharmaceutical Industries Europe BV

Polarisavenue 87, 2132 JH Hoofddorp, Nederland

EU/1/15/1030

28.5.2020.

20.5.2020.

Onpattro

Alnylam Netherlands B.V.

Strawinskylaan 3051, 1077 ZX, Amsterdam, Nederland

EU/1/18/1320

25.5.2020.

20.5.2020.

Pregabalin Zentiva

Zentiva, k.s.

U Kabelovny 130, 102 37 Praha 10, Česká republika

EU/1/15/1021

25.5.2020.

20.5.2020.

Revestive

Shire Pharmaceuticals Ireland Limited

Block 2 & 3 Miesian Plaza, 50-58 Baggot Street Lower, D02 Y754 Dublin 2, Ireland

EU/1/12/787

11.6.2020.

20.5.2020.

Tybost

Gilead Sciences Ireland UC

Carrigtohill, County Cork, T45 DP77, Ireland

EU/1/13/872

25.5.2020.

—   Izmjena odobrenja za stavljanje u promet (članak 13. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Odbijeno

| Datum odluke | Naziv lijeka | Nositelj odobrenja za stavljanje u promet | Broj upisa u registar Zajednice | Datum obavijesti |
| --- | --- | --- | --- | --- |
| 20.5.2020. | Emgality | Eli Lilly Nederland B.V.
  Papendorpseweg 83, 3528 BJ Utrecht, Nederland | EU/1/18/1330 | 27.5.2020. |

Datum odluke

Naziv lijeka

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Datum obavijesti

20.5.2020.

Emgality

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/18/1330

27.5.2020.

| — | Izdavanje odobrenja za stavljanje u promet (članak 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno |
| --- | --- |

—

Izdavanje odobrenja za stavljanje u promet (članak 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

| Datum odluke | Naziv lijeka | INN (medunarodni nezašticeni naziv lijeka) | Nositelj odobrenja za stavljanje u promet | Broj upisa u registar Zajednice | Farmaceutski oblik | Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova) | Datum obavijesti |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 18.5.2020. | Lydaxx | tulatromicin | VETOQUINOL S.A.
  Magny-Vernois, 70200 Lure, France | EU/2/20/253 | Otopina za injekciju | QJ01FA94 | 19.5.2020. |

Datum odluke

Naziv lijeka

INN (medunarodni nezašticeni naziv lijeka)

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Farmaceutski oblik

Oznaka ATC (Anatomsko-terapijsko-kemijska klasifikacija lijekova)

Datum obavijesti

18.5.2020.

Lydaxx

tulatromicin

VETOQUINOL S.A.

Magny-Vernois, 70200 Lure, France

EU/2/20/253

Otopina za injekciju

QJ01FA94

19.5.2020.

—   Izmjena odobrenja za stavljanje u promet (članak 38. Uredbe (EZ) br. 726/2004 Europskog parlamenta i Vijeća): Prihvaćeno

| Datum odluke | Naziv lijeka | Nositelj odobrenja za stavljanje u promet | Broj upisa u registar Zajednice | Datum obavijesti |
| --- | --- | --- | --- | --- |
| 4.5.2020. | Apoquel | Zoetis Belgium S.A.
  rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique | EU/2/13/154 | 7.5.2020. |
| 4.5.2020. | Loxicom | Norbrook Laboratories (Ireland) Limited
  Rossmore Industrial Estate, Monaghan, Ireland | EU/2/08/090 | 7.5.2020. |
| 12.5.2020. | Equilis Prequenza Te | Intervet International B.V.
  Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland | EU/2/05/057 | 15.5.2020. |
| 18.5.2020. | Equilis Prequenza | Intervet International B.V.
  Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland | EU/2/05/056 | 20.5.2020. |
| 18.5.2020. | Equilis Te | Intervet International B.V.
  Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland | EU/2/05/055 | 20.5.2020. |
| 27.5.2020. | CYTOPOINT | Zoetis Belgium S.A.
  rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique | EU/2/17/205 | 27.5.2020. |
| 27.5.2020. | Porcilis PCV ID | Intervet International B.V.
  Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland | EU/2/15/187 | 2.6.2020. |

Datum odluke

Naziv lijeka

Nositelj odobrenja za stavljanje u promet

Broj upisa u registar Zajednice

Datum obavijesti

4.5.2020.

Apoquel

Zoetis Belgium S.A.

rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/13/154

7.5.2020.

4.5.2020.

Loxicom

Norbrook Laboratories (Ireland) Limited

Rossmore Industrial Estate, Monaghan, Ireland

EU/2/08/090

7.5.2020.

12.5.2020.

Equilis Prequenza Te

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/05/057

15.5.2020.

18.5.2020.

Equilis Prequenza

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/05/056

20.5.2020.

18.5.2020.

Equilis Te

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/05/055

20.5.2020.

27.5.2020.

CYTOPOINT

Zoetis Belgium S.A.

rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/17/205

27.5.2020.

27.5.2020.

Porcilis PCV ID

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/15/187

2.6.2020.

Zainteresirane osobe koje žele na uvid dobiti javno izvješće o procjeni predmetnih lijekova i odluka koje se na njih odnose trebale bi se obratiti:

| European Medicines Agency |
| --- |
| Domenico Scarlattilaan 6 |
| 1083 HS Amsterdam |
| NETHERLANDS |

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS

---

(1)  SL L 136, 30.4.2004., str. 1.

---